Syntara has reported "outstanding" results for its ongoing myelofibrosis trial, raising hopes for sufferers of the rare blood ...
Stockhead on MSN
Lunch Wrap: ASX struggles as resources gain but banks falter
The ASX is looking mighty unsure of which direction to jump, seesawing as resource gains struggle to outweigh losses in ...
Healthinsurance.org analysts explain what’s changing – from higher out-of-pocket limits and expanded HSA eligibility to ...
CS Analytical Laboratory, the world's only FDA regulated contract laboratory exclusively dedicated to providing regulatory solutions and qualification testing services specifically for drug product ...
The Fund had a strong second quarter, outperforming its benchmarks, the Russell 1000 Growth Index and the S&P 500 Index. Read ...
Baron Durable Advantage Fund had a strong second quarter of 2025, outperforming its benchmark, the S&P 500 Index. Read more ...
StockStory.org on MSN
3 Services Stocks We’re Skeptical Of
Business services providers thrive by solving complex operational challenges for their clients, allowing them to focus on their secret sauce. These firms have helped their customers unlock huge ...
Over the years, I’ve seen firsthand how evolving standards and increasing demands for precision are reshaping the way the ...
What one Toyota dealer did with an inspection video may change how you look at service forever, and the unexpected reactions ...
StockStory.org on MSN
3 Profitable Stocks with Open Questions
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow. Profits ...
The Royal Devon University Healthcare NHS Foundation Trust and the University of Exeter have launched the RAPID-IBD study to speed up diagnosis o ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results